BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24991971)

  • 1. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
    Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
    Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes.
    Kalimuthu SN; Serra S; Dhani N; Chetty R
    J Clin Pathol; 2016 Jun; 69(6):463-71. PubMed ID: 26915370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
    Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
    Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and Diagnostic Strategies for Early-Stage Pancreatic Ductal Adenocarcinoma: A Retrospective Study.
    Kimura H; Ohtsuka T; Matsunaga T; Watanabe Y; Tamura K; Ideno N; Aso T; Miyazaki T; Osoegawa T; Aishima S; Miyasaka Y; Ueda J; Ushijima Y; Igarashi H; Ito T; Takahata S; Oda Y; Mizumoto K; Tanaka M
    Pancreas; 2015 Oct; 44(7):1148-54. PubMed ID: 26284536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary mucinous neoplasm undergoing partial pancreatectomy.
    Mori Y; Ohtsuka T; Tamura K; Ideno N; Aso T; Kono H; Nagayoshi Y; Ueda J; Takahata S; Aishima S; Ookubo F; Oda Y; Tanaka M
    Surgery; 2014 Jan; 155(1):67-73. PubMed ID: 24183345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma.
    Korpela T; Ristimäki A; Udd M; Vuorela T; Mustonen H; Haglund C; Kylänpää L; Seppänen H
    BMC Cancer; 2022 Jan; 22(1):23. PubMed ID: 34980011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting.
    Fujii T; Satoi S; Yamada S; Murotani K; Yanagimoto H; Takami H; Yamamoto T; Kanda M; Yamaki S; Hirooka S; Kon M; Kodera Y
    J Gastroenterol; 2017 Jan; 52(1):81-93. PubMed ID: 27169844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.
    Chatterjee D; Katz MH; Rashid A; Estrella JS; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Abbruzzese JL; Fleming JB; Wang H
    Histopathology; 2013 Dec; 63(6):841-51. PubMed ID: 24111684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.
    van Erning FN; Mackay TM; van der Geest LGM; Groot Koerkamp B; van Laarhoven HWM; Bonsing BA; Wilmink JW; van Santvoort HC; de Vos-Geelen J; van Eijck CHJ; Busch OR; Lemmens VE; Besselink MG;
    Acta Oncol; 2018 Dec; 57(12):1655-1662. PubMed ID: 30264642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
    Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
    Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients.
    Hwang IK; Kim H; Lee YS; Kim J; Cho JY; Yoon YS; Han HS; Hwang JH
    Cancer Sci; 2015 Oct; 106(10):1408-13. PubMed ID: 26183380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of inflammation in pancreatic cancer.
    Hausmann S; Kong B; Michalski C; Erkan M; Friess H
    Adv Exp Med Biol; 2014; 816():129-51. PubMed ID: 24818722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic characteristics of fibrous mass-forming chronic pancreatitis].
    Chang XJ; Chen Y; Zhang J; Shi M; Wang Y; Zhu MH
    Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):366-71. PubMed ID: 24060068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
    Takahashi M; Hori M; Ishigamori R; Mutoh M; Imai T; Nakagama H
    Cancer Sci; 2018 Oct; 109(10):3013-3023. PubMed ID: 30099827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.
    Saloman JL; Albers KM; Li D; Hartman DJ; Crawford HC; Muha EA; Rhim AD; Davis BM
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3078-83. PubMed ID: 26929329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma.
    Grace SA; Meeks MW; Chen Y; Cornwell M; Ding X; Hou P; Rutgers JK; Crawford SE; Lai JP
    Anticancer Res; 2017 Feb; 37(2):699-703. PubMed ID: 28179319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the management of pancreatic cancer: surgery is not enough.
    Ansari D; Gustafsson A; Andersson R
    World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic pancreatitis and resectable synchronous pancreatic carcinoma: A survival analysis.
    Birgin E; Hablawetz P; Téoule P; Rückert F; Wilhelm TJ
    Pancreatology; 2018 Jun; 18(4):394-398. PubMed ID: 29716797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma.
    Iwasaki T; Hiraoka N; Ino Y; Nakajima K; Kishi Y; Nara S; Esaki M; Shimada K; Katai H
    Cancer Sci; 2019 Apr; 110(4):1491-1502. PubMed ID: 30776178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.